Atlas Trials

Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients

Clinical trial NCT02654483 · COMPLETED

Trial details

NCT number
NCT02654483
Sponsor
Jean Yuh Tang
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Epidermolysis BullosaPruritus
Start date
2016-08-31
Primary completion
2018-06-28
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.